BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 27663109)

  • 1. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonverbal communication and conversational contribution in breast cancer genetic counseling: are counselors' nonverbal communication and conversational contribution associated with counselees' satisfaction, needs fulfillment and state anxiety in breast cancer genetic counseling?
    Dijkstra H; Albada A; Klöckner Cronauer C; Ausems MG; van Dulmen S
    Patient Educ Couns; 2013 Nov; 93(2):216-23. PubMed ID: 23786807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial consequences of genetic counseling: a population-based follow-up study.
    Mikkelsen EM; Sunde L; Johansen C; Johnsen SP
    Breast J; 2009; 15(1):61-8. PubMed ID: 19120380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
    Voorwinden JS; Jaspers JP
    J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up effects of a tailored pre-counseling website with question prompt in breast cancer genetic counseling.
    Albada A; van Dulmen S; Spreeuwenberg P; Ausems MG
    Patient Educ Couns; 2015 Jan; 98(1):69-76. PubMed ID: 25455796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Centered Care in Breast Cancer Genetic Clinics.
    Brédart A; Anota A; Dick J; Kuboth V; Lareyre O; De Pauw A; Cano A; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S; Kop JL
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29439543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
    Medendorp NM; van Maarschalkerweerd PEA; Murugesu L; Daams JG; Smets EMA; Hillen MA
    Patient Educ Couns; 2020 Sep; 103(9):1692-1708. PubMed ID: 32278626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
.
    Fournier DM; Bazzell AF; Dains JE
    Oncol Nurs Forum; 2018 Jan; 45(1):96-105. PubMed ID: 29251290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counselee participation in follow-up breast cancer genetic counselling visits and associations with achievement of the preferred role, cognitive outcomes, risk perception alignment and perceived personal control.
    Albada A; Ausems MG; van Dulmen S
    Soc Sci Med; 2014 Sep; 116():178-86. PubMed ID: 25016325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
    Eijzenga W; Bleiker EM; Hahn DE; Kluijt I; Sidharta GN; Gundy C; Aaronson NK
    Psychooncology; 2014 Aug; 23(8):862-9. PubMed ID: 24443031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions.
    Brédart A; Anota A; Dick J; Cano A; De Pauw A; Kop JL; Aaronson NK; Bleiker EM; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13173. PubMed ID: 31571365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial.
    Albada A; van Dulmen S; Bensing JM; Ausems MG
    Breast Cancer Res; 2012 Mar; 14(2):R37. PubMed ID: 22394647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
    Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
    Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.
    Albada A; van Dulmen S; Dijkstra H; Wieffer I; Witkamp A; Ausems MG
    J Genet Couns; 2016 Apr; 25(2):279-89. PubMed ID: 26321750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.